Literature DB >> 29151166

T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.

Stephen Harward1, S Harrison Farber1, Michael Malinzak2, Oren Becher3, Eric M Thompson4,5.   

Abstract

PURPOSE: Diffuse intrinsic pontine glioma (DIPG) remains the main cause of death in children with brain tumors. Given the inefficacy of numerous peripherally delivered agents to treat DIPG, convection enhanced delivery (CED) of therapeutic agents is a promising treatment modality. The purpose of this study was to determine which MR imaging type provides the best discrimination of intratumoral heterogeneity to guide future stereotactic implantation of CED catheters into the most cellular tumor regions.
METHODS: Patients ages 18 years or younger with a diagnosis of DIPG from 2000 to 2015 were included. Radiographic heterogeneity index (HI) of the tumor was calculated by measuring the standard deviation of signal intensity of the tumor (SDTumor) normalized to the genu of the corpus callosum (SDCorpus Callosum). Four MR image types (T2-weighted, contrast-enhanced T1-weighted, FLAIR, and ADC) were analyzed at several time points both before and after radiotherapy and chemotherapy. HI values across these MR image types were compared and correlated with patient survival.
RESULTS: MR images from 18 patients with DIPG were evaluated. The mean survival ± standard deviation was 13.8 ± 13.7 months. T2-weighted images had the highest HI (mean ± SD, 5.1 ± 2.5) followed by contrast-enhanced T1-weighted images (3.7 ± 1.5), FLAIR images (3.0 ± 1.1), and ADC maps (1.6 ± 0.4). ANOVA demonstrated that HI values were significantly higher for T2-weighted images than FLAIR (p < 0.01) and ADC (p < 0.0001). Following radiotherapy, T2-weighted and contrast-enhanced T1-weighted image HI values increased, while FLAIR and ADC HI values decreased. Univariate and multivariate analyses did not reveal a relationship between HI values and patient survival (p > 0.05).
CONCLUSIONS: For children with DIPG, T2-weighted MRI demonstrates the greatest signal intensity variance suggesting tumor heterogeneity. Within this heterogeneity, T2-weighted signal hypointensity is known to correlate with increased cellularity and thus may represent a putative target for CED catheter placement in future clinical trials.

Entities:  

Keywords:  Convection enhanced delivery; DIPG; Diffuse intrinsic pontine glioma; MRI; T2; Tumor heterogeneity

Mesh:

Year:  2017        PMID: 29151166     DOI: 10.1007/s00381-017-3659-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  28 in total

1.  Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion.

Authors:  Russell R Lonser; Stuart Walbridge; Kayhan Garmestani; John A Butman; Hugh A Walters; Alexander O Vortmeyer; Paul F Morrison; Martin W Brechbiel; Edward H Oldfield
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

Review 2.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Authors:  Therese A Dolecek; Jennifer M Propp; Nancy E Stroup; Carol Kruchko
Journal:  Neuro Oncol       Date:  2012-11       Impact factor: 12.300

3.  MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).

Authors:  Tina Young Poussaint; Mehmet Kocak; Sridhar Vajapeyam; Roger I Packer; Richard L Robertson; Russell Geyer; Daphne Haas-Kogan; Ian F Pollack; Gilbert Vezina; Robert Zimmerman; Soonmee Cha; Zoltan Patay; James M Boyett; Larry E Kun
Journal:  Neuro Oncol       Date:  2011-02-04       Impact factor: 12.300

Review 4.  Role of MRI in the management of children with diffuse pontine tumors: a study of 15 patients and review of the literature.

Authors:  Liora Kornreich; Michael Schwarz; Boaz Karmazyn; Ian J Cohen; Avinoam Shuper; Shalom Michovitz; Issac Yaniv; Eyal Fenig; Gadi Horev
Journal:  Pediatr Radiol       Date:  2005-05-26

5.  MRI Evaluation of Non-Necrotic T2-Hyperintense Foci in Pediatric Diffuse Intrinsic Pontine Glioma.

Authors:  O Clerk-Lamalice; W E Reddick; X Li; Y Li; A Edwards; J O Glass; Z Patay
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

6.  Conventional MRI at presentation does not predict clinical response to radiation therapy in children with diffuse pontine glioma.

Authors:  Arthur K Liu; Jonathan Brandon; Nicholas K Foreman; Laura Z Fenton
Journal:  Pediatr Radiol       Date:  2009-08-06

Review 7.  Advances toward an understanding of brainstem gliomas.

Authors:  Sarah S Donaldson; Fred Laningham; Paul Graham Fisher
Journal:  J Clin Oncol       Date:  2006-03-10       Impact factor: 44.544

Review 8.  Diffuse intrinsic pontine gliomas: treatments and controversies.

Authors:  Amy Lee Bredlau; David N Korones
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  Interstitial fluid pressure in intracranial tumours in patients and in rodents.

Authors:  Y Boucher; H Salehi; B Witwer; G R Harsh; R K Jain
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 10.  Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma.

Authors:  Pawel Buczkowicz; Cynthia Hawkins
Journal:  Front Oncol       Date:  2015-06-30       Impact factor: 6.244

View more
  3 in total

1.  ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma.

Authors:  Vadim Tsvankin; Rintaro Hashizume; Hiroaki Katagi; James E Herndon; Christopher Lascola; Talaignair N Venkatraman; Daniel Picard; Brainard Burrus; Oren J Becher; Eric M Thompson
Journal:  Neurosurgery       Date:  2020-05-01       Impact factor: 4.654

2.  Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features.

Authors:  Raphaël Calmon; Volodia Dangouloff-Ros; Pascale Varlet; Christophe Deroulers; Cathy Philippe; Marie-Anne Debily; David Castel; Kevin Beccaria; Thomas Blauwblomme; David Grevent; Raphael Levy; Charles-Joris Roux; Yvonne Purcell; Ana Saitovitch; Monica Zilbovicius; Christelle Dufour; Stéphanie Puget; Jacques Grill; Nathalie Boddaert
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

3.  Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy.

Authors:  Andrew Deweyert; Erin Iredale; Hu Xu; Eugene Wong; Susanne Schmid; Matthew O Hebb
Journal:  J Neurooncol       Date:  2019-03-09       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.